{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:50:53Z","timestamp":1773294653444,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.genhosppsych.2006.10.011","type":"journal-article","created":{"date-parts":[[2006,12,26]],"date-time":"2006-12-26T09:08:01Z","timestamp":1167124081000},"page":"75-77","source":"Crossref","is-referenced-by-count":11,"title":["Olanzapine-induced agranulocytosis in systemic lupus erythematosus: a case report"],"prefix":"10.1016","volume":"29","author":[{"given":"Jian-An","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hin-Yeung","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.genhosppsych.2006.10.011_bib1","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1191\/0961203303lu507oa","article-title":"A psychiatric perspective on the therapy of psychosis in systemic lupus erythematosus","volume":"12","author":"Bodani","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib2","doi-asserted-by":"crossref","first-page":"s7","DOI":"10.1097\/00001504-200303001-00003","article-title":"Critical review and summary of information about the effects and safety of second-generation antipsychotic medications","volume":"16","author":"Sartorius","year":"2003","journal-title":"Curr Opin Psychiatry"},{"issue":"Suppl 10","key":"10.1016\/j.genhosppsych.2006.10.011_bib3","first-page":"13","article-title":"Safety of olanzapine","volume":"58","author":"Beasley","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00004850-199805000-00007","article-title":"Olanzapine treatment in patients with typical and atypical neuroleptic-associated agranulocytosis","volume":"13","author":"Finkel","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0300-483X(02)00255-X","article-title":"The danger hypothesis \u2014 potential role in idiosyncratic drug reactions","volume":"181-182","author":"Pirmohamed","year":"2002","journal-title":"Toxicology"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0009-2797(02)00061-3","article-title":"Predicting drug-induced agranulocytosis: characterizing neutrophil-generated metabolites of a model compound, DMP 406, and assessing the relevance of an in vitro apoptosis assay for identifying drugs that may cause agranulocytosis","volume":"142","author":"Iverson","year":"2002","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1600-0447.2000.102002153.x","article-title":"Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia","volume":"102","author":"Schuld","year":"2000","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(99)00957-5","article-title":"Olanzapine-induced neutropenia after clozapine-induced neutropenia","volume":"354","author":"Benedetti","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.psy.41.2.150","article-title":"Olanzapine-induced neutropenia","volume":"41","author":"Gajwani","year":"2000","journal-title":"Psychosomatics"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib10","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1176\/appi.ajp.158.10.1736-a","article-title":"Agranulocytosis and neutropenia with typical and atypical neuroleptics","volume":"158","author":"Hong","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib11","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4088\/JCP.v61n1111b","article-title":"Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution","volume":"61","author":"Teter","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004850-200101000-00007","article-title":"Olanzapine-induced leukopenia with human leukocyte antigen profiling","volume":"16","author":"Buchman","year":"2001","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib13","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.pnpbp.2005.04.025","article-title":"Olanzapine-induced leucopenia and neutropenia","volume":"29","author":"Stergiou","year":"2005","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1176\/appi.psy.44.1.83","article-title":"Olanzapine and haloperidol: potential for neutropenia?","volume":"44","author":"Abdullah","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0278-5846(01)00258-5","article-title":"Olanzapine-induced agranulocytosis: a case report and review of the literature","volume":"26","author":"Tolosa-Vilella","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.genhosppsych.2006.10.011_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00004850-200103000-00007","article-title":"Dose-dependent olanzapine-associated leukopenia: three case reports","volume":"16","author":"Kodesh","year":"2001","journal-title":"Int Clin Psychopharmacol"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834306002106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834306002106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T08:55:24Z","timestamp":1547110524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834306002106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0163834306002106"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2006.10.011","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}